Procurement Summary
Country: Brazil
Summary: Acquisition of Medicines to Meet Legal Demands.
Deadline: 27 Apr 2026
Posting Date: 13 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139457934
Document Ref. No.: 90230/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Object: Electronic Auction - Acquisition of Medicines to meet Legal Demands. UASG code: 90201 Notice from: 04/13/2026 from 08:00 to 12:00 and from 13:00 to 17:59 Proposal Delivery: from 04/13/2026 at 08:00 EZETIMIBA, COMPOSITION ASSOCIATED WITH ROSUVASTATIN, CONCENTRATION 10MG + 10 MG Quantity: 720 FEXOFENADINE, DOSAGE 120MG Quantity: 180 IXEKIZUMAB, CONCENTRATION 80 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS SYRINGE COMPLETED Quantity: 19 MIDOSTAURIN, CONCENTRATION 25 MG Quantity: 1200 OFATUMUMAB, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 25 PITAVASTATIN, CALCIUM COMPOSITION, CONCENTRATION 4 MG Quantity: 150 MUCOPOLYSACCHARIDE, POLYSULFATE COMPOSITION, CONCENTRATION 5 MG/G, PHARMACEUTICAL GEL FORM Quantity: 1080 PROMESTRIEN, CONCENTRATION 10 MG/G, PHARMACEUTICAL FORM VAGINAL CREAM Quantity: 180 PRUCALOPRIDE, CONCENTRATION 2 MG Quantity: 720 SAFINAMIDE, CONCENTRATION 50 MG Quantity: 180 TEZEPELUMAB, CONCENTRATION 110 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS FILLED SYRINGE Quantity: 5 TRASTUZUMAB, DERUXTECAN COMPOSITION, CONCENTRATION 100 MG, PHARMACEUTICAL FORM LYOPHIL POWDER INJETÁVEL Quantity: 111 VALSARTAN, COMPOSITION ASSOCIATED WITH HYDROCHLOROTHIAZIDE, ANLODIPINE BESILATE, CONCENTRATION 320 MG + 25 MG + 10 MG Quantity: 360 VENLAFAXINE, COMPOSITION HYCLORYDRATE SALT, CONCENTRATION 37.5 MG, PHARMACEUTICAL FORM RELEASE CONTROLLED Quantity: 150 VISMODEGIBE, CONCENTRATION 150 MG Quantity: 360
Documents
Tender Notice